Fundraising Fox

JJDCFull Portfolio

5 tracked investments · listed companies and verified rows first

Protagonist Therapeuticsprotagonist-inc.comin𝕏NASDAQ: PTGXJul 2015

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsAisling CapitalCanaan PartnersLilly VenturesStarfish Ventures

Aetionaetion.comin

Data & InfrastructureDigital HealthHealthtechNew York, US

Sebastian G. Schneeweiss(Director)William Geary(Director)inJeremy Rassen(Executive Officer, Director)

Co-investorsB Capital GroupB4 CapitalBlue Lion GlobalFlare Capital PartnersForesite CapitalLG Technology Ventures+4 more

Nucleomenucleome.com

Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.

AI & Machine LearningBiotechDeep Tech

Co-investorsM VenturesOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalPfizer Ventures

Rodin Therapeuticsrodintherapeutics.comAug 2017

HealthtechCambridge, US

Adam Rosenberg(Executive Officer, Director)

BoardBruce Booth(Director)Kees Been(Director)Samantha Singer(Director)

Co-investorsGV (Google Ventures)Hatteras Venture PartnersThird Point VenturesAtlas VentureRemeditex Ventures

Ronovo Surgicalronovosurgical.cominSep 2025 · $67M

Ronovo Surgical develops the Carina surgical robotics platform, including a vision system and instruments, for use by surgeons and hospitals.

HealthtechMedical DevicesRobotics

John MaYing Mao

Co-investorsGranite AsiaINCE CapitalVivo CapitalLilly Asia Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.